Evidence map›Paper›PMID 31431687›Full record

ArticleScientific reports2019

Upregulation of miR-17-92 cluster is associated with progression and lymph node metastasis in oesophageal adenocarcinoma.

Patrick Sven Plum, Ute Warnecke-Eberz, Uta Drebber, Seung-Hun Chon, Hakan Alakus, Arnulf Heinrich Hölscher, Alexander Quaas, Christiane Josephine Bruns, Ines Gockel, Dietmar Lorenz and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.8field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 16 citations in OpenAlex.

  1. miRNA profiling of esophageal adenocarcinoma using transcriptome analysis.Cancer biomarkers : section A of Disease markers · 2024
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Role of miRNA-19a in Cancer Diagnosis and Poor Prognosis.International journal of molecular sciences · 2021
    Review
  11. Review
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Patrick Sven PlumDepartment of General, Visceral and Cancer Surgery, University of Cologne, Faculty of Medicine and University Hospital Cologne, Kerpener Straße 62, D-50937, Cologne, Germany. patrick.plum@uk-koeln.de.ORCID http://orcid.org/0000-0002-8165-4553
Ute Warnecke-EberzDepartment of General, Visceral and Cancer Surgery, University of Cologne, Faculty of Medicine and University Hospital Cologne, Kerpener Straße 62, D-50937, Cologne, Germany.
Uta DrebberInstitute of Pathology, University of Cologne, Faculty of Medicine and University Hospital Cologne, Kerpener Straße 62, D-50937, Cologne, Germany.
Seung-Hun ChonDepartment of General, Visceral and Cancer Surgery, University of Cologne, Faculty of Medicine and University Hospital Cologne, Kerpener Straße 62, D-50937, Cologne, Germany.ORCID http://orcid.org/0000-0002-8923-6428
Hakan AlakusDepartment of General, Visceral and Cancer Surgery, University of Cologne, Faculty of Medicine and University Hospital Cologne, Kerpener Straße 62, D-50937, Cologne, Germany.
Arnulf Heinrich HölscherCenter for Oesophageal and Gastric Surgery, AGAPLESION Markus Krankenhaus, Wilhelm-Epstein-Straße 4, D-60431, Frankfurt am Main, Germany.
Alexander QuaasInstitute of Pathology, University of Cologne, Faculty of Medicine and University Hospital Cologne, Kerpener Straße 62, D-50937, Cologne, Germany.
Christiane Josephine BrunsDepartment of General, Visceral and Cancer Surgery, University of Cologne, Faculty of Medicine and University Hospital Cologne, Kerpener Straße 62, D-50937, Cologne, Germany.
Ines GockelDepartment of Visceral, Transplant, Thoracic and Vascular Surgery, University Medical Center Leipzig, Liebigstraße 20, D- 04103, Leipzig, Germany.
Dietmar LorenzDepartment of General, Visceral and Thoracic Surgery, Klinikum Darmstadt GmbH, Grafenstraße 9, D-64283, Darmstadt, Germany.
Ralf MetzgerDepartment of General, Visceral, Thoracic and Cancer Surgery, CaritasKlinikum Saarbrücken, Rheinstraße 2, D-66113, Saarbrücken, Germany.
Elfriede BollschweilerDepartment of General, Visceral and Cancer Surgery, University of Cologne, Faculty of Medicine and University Hospital Cologne, Kerpener Straße 62, D-50937, Cologne, Germany.
University of Cologne · DEAgaplesion Markus Hospital · DEcts CaritasKlinikum Saarbrücken · DEKlinikum Darmstadt · DEUniversity Hospital Leipzig · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The occurrence of lymph node metastasis (LNM) and depth of tumour infiltration are significant prognostic factors in oesophageal adenocarcinoma (OAC), however no reliable prognostic biomarkers have been established so far. Aim of this study was to characterize microRNAs (miRs) of OAC patients, who primarily underwent oesophagectomy, in order to identify specific alterations during tumour progression and LNM. MicroRNA array-based quantification analysis of 754 miRs, including tumour specimens of 12 patients with pT2 OAC from three different centres (detection group), was performed. We identified miR-17, miR-19a/b, miR-20a, and miR-106a, showing the best predictive power for LNM. These miRs were validated by quantitative real time-PCR (qRT-PCR) in 43 patients with different tumour stages (pT1: n = 21; pT2: n = 12 and pT3: n = 10) (training group) (p < 0.05), demonstrating that increasing levels of identified miRs were associated with advanced depth of tumour infiltration. These findings were verified in another independent group of 46 pT2 OAC patients (validation group). Quantitative RT-PCR analysis of the miR-panel confirmed these results except for miR-19a (p < 0.05 each). Logistic regression analysis identified miR-17 and miR-20a (p = 0.025 and p = 0.022, respectively) to be independent variables for prediction of LNM. The mathematical prediction model was used in the validation group, and the estimated prognosis was compared to the actual postsurgical follow-up. This comprehensive data demonstrated the importance of miR-17-92 cluster and miR-106a for progression as well as LNM in OAC indicating that those might be feasible prognostic biomarkers.

Indexed as

AdenocarcinomaAdultAgedAged, 80 and overBiomarkers, TumorCohort StudiesEsophageal NeoplasmsFemaleHumansLymphatic MetastasisMaleMicroRNAsMiddle AgedModels, TheoreticalPrognosisRNA, Long NoncodingBiomarkers, TumorMicroRNAsMIR17HG, humanMIRN106 microRNA, humanMIRN17 microRNA, humanMIRN19A microRNA, humanMIRN20a microRNA, humanRNA, Long Noncoding

Identifiers

PMID31431687
PMCPMC6702344
OpenAlexW2969417115

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.